COVID trial is closed to enrollment but we will notify our community of upcoming COVID trials.
Randomize Now’s mission is to increase clinical research participation within the black community by educating, ensuring accessibility, and displaying cultural competency.
We utilize traditional and modern platforms to educate the community on active trials and participation requirements.
We are cognizant of clinical research concerns across cultures so we address volunteers with compassion .
We comply with ethical and legal regulations to ensure high yield and quality results for our sponsors and CROs.
Randomize Now is working to contribute meaningful information to healthcare so that patients from all ethnicities, races, and backgrounds have access to relevant medical treatments and interventions. This starts with clinical trial participants reflecting patient populations … Supporting our mission to ensure everyone is #Accounted4NOW
Active Clinical Trials in US
% black participants at Randomize Now
% black participants nationally
Due for a colonoscopy? Help researchers develop non-invasive cancer testing methods using a simple blood draw. Compensation up to $250.
We are looking for participants for a research study that explores the possibility of a non-invasive method of detecting colorectal cancer through a blood test. Your participation could change how colorectal cancer is detected in the future.
Over 43 million people in the USA have tested positive for COVID-19. However careful we are, more people receive a positive test result every day. That’s why, despite the development of vaccines, we need to keep researching treatment options for people with COVID-19.
Our mission is to close the cultural gap in study populations by building trust in communities and making research opportunities readily available.
We are following Covid-19 protocol in our clinic.
